Does Quartz Health Solutions Cover Lipitor?

At a glance
- Generic atorvastatin / available since 2011 after Lipitor patent expiration
- Typical formulary tier / generic atorvastatin usually placed on Tier 1 or Tier 2 (preferred generic)
- Brand Lipitor / often Tier 3 or non-preferred; may require prior authorization or step therapy
- Copay range / generic statins typically cost $0 to $20/month under most commercial plans
- Clinical use / lowers LDL cholesterol by 39% to 60% depending on dose
- AHA/ACC guideline status / atorvastatin is a first-line high-intensity statin
- Preventive coverage / many ACA-compliant plans cover statins with $0 copay for qualifying adults
- Quartz service area / primarily Wisconsin and parts of Illinois, Iowa, and Minnesota
- Formulary updates / Quartz revises its drug list at least annually; always verify current tier
- Appeal process / members can request a formulary exception if brand Lipitor is medically necessary
How Quartz Health Solutions Handles Statin Coverage
Quartz Health Solutions, a regional health plan headquartered in Madison, Wisconsin, maintains a tiered formulary that categorizes prescription drugs by cost-sharing level. Generic atorvastatin typically sits on the lowest or second-lowest tier, which translates to the smallest copay for members. Brand-name Lipitor may appear on a higher, non-preferred tier or may not be listed at all.
This tiering system reflects a broader industry pattern. After Pfizer's patent on atorvastatin expired in November 2011, generic manufacturers flooded the market, dropping the average wholesale price from roughly $5.50 per tablet (brand) to under $0.15 per tablet (generic) within two years. The FDA considers generic atorvastatin bioequivalent to brand Lipitor, meaning it delivers the same clinical effect at the same dose [1]. Because of this bioequivalence, nearly every commercial insurer in the United States, Quartz included, now prefers the generic version.
If your Quartz plan is sold through the Health Insurance Marketplace (ACA exchange), there is an additional layer of coverage worth knowing. The U.S. Preventive Services Task Force (USPSTF) issued a Grade B recommendation for statin use in adults aged 40 to 75 who have at least one cardiovascular risk factor and a 10-year cardiovascular event risk of 10% or greater [2]. Under Section 2713 of the Affordable Care Act, ACA-compliant plans must cover Grade B preventive services with zero cost-sharing. This means qualifying Quartz members may pay nothing out of pocket for generic atorvastatin.
Why Atorvastatin Is the Default Formulary Choice
Atorvastatin earned its place on virtually every insurer's preferred list through decades of clinical evidence. The drug is the most widely prescribed statin in the world for good reason.
The Collaborative Atorvastatin Diabetes Study (CARDS, N=2,838) demonstrated that atorvastatin 10 mg reduced major cardiovascular events by 37% in patients with type 2 diabetes and no prior history of cardiovascular disease (HR 0.63 to 95% CI 0.48 to 0.83) [3]. The trial was stopped two years early because the benefit was so clear. Separately, the SPARCL trial (N=4,731) showed that atorvastatin 80 mg reduced recurrent stroke by 16% in patients with recent stroke or transient ischemic attack [4].
The 2018 AHA/ACC Cholesterol Clinical Practice Guideline specifically names atorvastatin 40 to 80 mg as a high-intensity statin option, alongside rosuvastatin 20 to 40 mg [5]. The guideline states: "High-intensity statin therapy should be initiated or continued as first-line therapy in adults 40 to 75 years of age with clinical ASCVD." This recommendation makes atorvastatin a cornerstone drug that insurers have strong incentive to cover.
Dr. Scott Grundy, chair of the 2018 AHA/ACC guideline writing committee, noted: "Statins remain the foundation of atherosclerotic cardiovascular disease risk reduction. The evidence base for atorvastatin and rosuvastatin at high-intensity doses is extensive and consistent across diverse populations" [5].
Checking Your Specific Quartz Formulary
Not all Quartz plans use the same formulary. Your exact coverage depends on whether you hold a Quartz Medicare Advantage plan, a Quartz commercial HMO or PPO, or a Quartz Marketplace (ACA) plan. Each product line may use a different drug list.
To verify your coverage, take these steps. First, log into your Quartz member portal at quartz.com and manage to the "Pharmacy" or "Formulary" section. Search for "atorvastatin" (generic) and "Lipitor" (brand) separately, because they may have different tier placements. Second, look at the tier number and any coverage restrictions listed. Common restrictions include prior authorization (PA), step therapy (ST), and quantity limits (QL). Third, call the number on the back of your Quartz member ID card if you cannot find the information online. Ask the representative to confirm the tier, copay, and any required steps before filling.
Quartz updates its formulary periodically. A drug's tier can change at the start of a new plan year or during mid-year formulary revisions. If you checked six months ago, check again.
What to Do If Brand Lipitor Is Required
Some patients need brand-name Lipitor rather than generic atorvastatin. This situation is uncommon but not impossible. A patient might experience adverse effects with one manufacturer's generic formulation (due to inactive ingredient differences) while tolerating the brand product. The FDA acknowledges that inactive ingredients can occasionally cause allergic reactions or intolerances in sensitive individuals [6].
If your prescriber determines that brand-name Lipitor is medically necessary, you or your provider can submit a formulary exception request to Quartz. The process generally works as follows. Your prescriber writes a letter of medical necessity explaining why the generic version is not appropriate. Quartz reviews the request, typically within 72 hours for standard requests or 24 hours for expedited (urgent) requests. If approved, Quartz may cover brand Lipitor at a preferred tier or waive the usual tier differential.
If denied, you have the right to appeal. Wisconsin's Office of the Commissioner of Insurance oversees external review processes for health plan coverage disputes, giving members a path beyond the insurer's internal appeals.
Cost Comparison: Generic Atorvastatin vs. Brand Lipitor
The price gap between generic atorvastatin and brand Lipitor is enormous. Understanding this gap explains why insurers push the generic so aggressively.
A 30-day supply of generic atorvastatin 20 mg costs approximately $4 to $15 at most retail pharmacies, even without insurance. Walmart, Costco, and several grocery-chain pharmacies include atorvastatin on their $4 generic lists. With Quartz Tier 1 coverage, your copay is likely in the $0 to $10 range. Brand-name Lipitor, by contrast, carries a retail price of $400 to $500 per month without insurance. Even with Quartz coverage at a non-preferred brand tier, a member might face a $50 to $100+ copay.
A 2022 analysis published in JAMA Network Open examined statin adherence patterns among 8.2 million commercially insured adults and found that patients assigned to lower formulary tiers had 12% higher medication adherence at 12 months compared to those on higher-tier statins (adjusted OR 1.12 to 95% CI 1.09 to 1.15) [7]. The implication is straightforward: lower out-of-pocket costs help people stay on their medication.
For patients who want to minimize cost further, several options exist. GoodRx and similar discount platforms often show atorvastatin prices below $10 for a 90-day supply. Mail-order pharmacy through Quartz (if available in your plan) typically offers a 90-day supply for two copays instead of three. Manufacturer discount cards exist for brand Lipitor, though they generally exclude government-insured patients.
Atorvastatin Dosing and What Your Plan Covers
Atorvastatin comes in 10 mg, 20 mg, 40 mg, and 80 mg tablets. Quartz's formulary typically covers all four strengths at the same tier for the generic, though quantity limits may apply.
The 2018 AHA/ACC guidelines divide statin therapy into three intensity categories [5]. High-intensity therapy (atorvastatin 40 to 80 mg) lowers LDL cholesterol by approximately 50% or more. Moderate-intensity therapy (atorvastatin 10 to 20 mg) lowers LDL by 30% to 49%. The PROVE IT-TIMI 22 trial (N=4,162) compared atorvastatin 80 mg against pravastatin 40 mg in patients after acute coronary syndrome and found that high-intensity atorvastatin reduced the composite endpoint of death, myocardial infarction, unstable angina, revascularization, and stroke by 16% over two years (p<0.005) [8].
Most Quartz plans do not require prior authorization for any strength of generic atorvastatin. However, if your prescriber writes for an unusually high quantity (for example, more than 30 tablets for a 30-day period), the pharmacy may trigger a quantity limit edit. This is easily resolved with a call from the prescriber's office.
Quartz Medicare Advantage and Lipitor Coverage
Quartz offers Medicare Advantage plans in select Wisconsin counties. Medicare Part D formularies follow CMS (Centers for Medicare & Medicaid Services) guidelines, which require coverage of "all or substantially all" drugs in certain protected classes. Statins are not a CMS-protected class, but they are so widely used that virtually every Part D plan covers at least one or two statins.
On Quartz Medicare Advantage formularies, generic atorvastatin is typically Tier 1 (preferred generic) with a copay of $0 to $10 during the initial coverage phase. Once a member enters the coverage gap (the "donut hole"), they pay 25% of the negotiated price for generic drugs under the current Medicare Part D benefit structure [9]. For generic atorvastatin, 25% of a $10 negotiated price is $2.50, which remains affordable.
Brand Lipitor on a Medicare Part D formulary, if listed at all, usually sits on Tier 3 (preferred brand) or Tier 4 (non-preferred brand). The coverage gap cost for brand drugs is also 25% of the total cost, but 25% of a $400 brand price is $100 per fill. This is one more reason to use the generic whenever clinically appropriate.
Alternatives If Coverage Is Denied
If for any reason Quartz does not cover atorvastatin or Lipitor, or if the cost-sharing is higher than expected, several therapeutic alternatives exist.
Rosuvastatin (generic Crestor) is the other high-intensity statin and may be on a different (possibly lower) tier on your Quartz formulary. A 2015 meta-analysis in The Lancet (N=174,149 across 27 trials) found that each 1 mmol/L (approximately 39 mg/dL) reduction in LDL cholesterol with statin therapy reduced major vascular events by about 22% (RR 0.78 to 95% CI 0.76 to 0.80), regardless of which statin was used [10]. This means switching between statins does not sacrifice cardiovascular protection, as long as the LDL reduction target is met.
Simvastatin, pravastatin, and lovastatin are moderate-intensity alternatives, all available as low-cost generics. For patients who cannot tolerate any statin, ezetimibe (generic Zetia) and PCSK9 inhibitors (evolocumab, alirocumab) represent non-statin LDL-lowering options, though PCSK9 inhibitors carry significantly higher costs and stricter prior authorization requirements.
Your Quartz pharmacist or the plan's clinical pharmacist can run a therapeutic alternative search and identify which LDL-lowering drug on your specific formulary offers the best combination of efficacy and affordability.
Preventive Statin Coverage Under the ACA
The Affordable Care Act's preventive care mandate deserves its own discussion because it can eliminate your statin copay entirely. As noted earlier, the USPSTF gives statin therapy a Grade B recommendation for adults aged 40 to 75 with cardiovascular risk factors and a calculated 10-year ASCVD risk of 10% or higher [2].
When a statin prescription meets these criteria, ACA-compliant Quartz plans must cover it at $0 cost-sharing. No copay. No deductible. No coinsurance. This applies to generic statins only, not brand-name Lipitor. The prescriber may need to document that the prescription is for primary prevention of cardiovascular disease to trigger the $0 coverage.
The USPSTF recommendation was based in part on data from the Jupiter trial (N=17,802), which demonstrated that rosuvastatin 20 mg reduced first cardiovascular events by 44% (HR 0.56 to 95% CI 0.46 to 0.69) in apparently healthy individuals with elevated high-sensitivity C-reactive protein [11]. While the Jupiter trial used rosuvastatin, the USPSTF recommendation applies broadly to statin therapy, including atorvastatin.
Not every statin prescription qualifies for $0 preventive coverage. If the prescription is for secondary prevention (the patient already has established cardiovascular disease), or if the patient falls outside the 40 to 75 age range, standard formulary cost-sharing applies. Ask your prescriber whether your statin qualifies under the USPSTF recommendation.
How to Appeal a Quartz Coverage Decision
If Quartz denies coverage for atorvastatin or Lipitor, or places it on a tier you believe is incorrect, you can challenge the decision through a structured appeals process.
Start with an internal appeal. Call Quartz member services and request a coverage determination review. Provide any clinical documentation from your prescriber supporting the medical necessity of the specific drug and formulation. Quartz must respond to a standard pre-service appeal within 30 days, or within 72 hours for an expedited appeal involving urgent medical circumstances.
If the internal appeal is denied, you may request an external review through an independent review organization (IRO). Wisconsin state law (Wis. Stat. § 632.835) requires health insurers to comply with external review decisions. The IRO's determination is binding on the insurer.
Throughout this process, document every call and letter. Keep copies of your Explanation of Benefits (EOB), denial letters, and all correspondence. If you have trouble navigating the process, the Wisconsin Office of the Commissioner of Insurance (oci.wi.gov) offers consumer assistance.
Frequently asked questions
›Does Quartz Health Solutions cover Lipitor?
›Is generic atorvastatin the same as brand Lipitor?
›How much does atorvastatin cost with Quartz insurance?
›Can I get Lipitor for free with Quartz?
›What if my doctor says I need brand-name Lipitor?
›Does Quartz require prior authorization for atorvastatin?
›What are alternatives to Lipitor that Quartz might cover?
›How do I check my Quartz formulary online?
›Does Quartz Medicare Advantage cover Lipitor?
›What happens if I hit the Medicare donut hole while taking atorvastatin?
›Can I use a discount card instead of Quartz for atorvastatin?
›How long does a Quartz formulary exception take?
References
- U.S. Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book): Atorvastatin. https://www.accessdata.fda.gov/scripts/cder/ob/
- U.S. Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement. JAMA. 2022;328(8):746-753. https://pubmed.ncbi.nlm.nih.gov/35997723/
- Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-696. https://pubmed.ncbi.nlm.nih.gov/15325833/
- Amarenco P, Bogousslavsky J, Callahan A III, et al. High-dose atorvastatin after stroke or transient ischemic attack (SPARCL). N Engl J Med. 2006;355(6):549-559. https://pubmed.ncbi.nlm.nih.gov/16899775/
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350. https://pubmed.ncbi.nlm.nih.gov/30423393/
- U.S. Food and Drug Administration. Generic Drugs: Questions and Answers. https://www.fda.gov/drugs/frequently-asked-questions-popular-topics/generic-drugs-questions-answers
- Choudhry NK, Tong A, Engel S, et al. Statin formulary tier and adherence outcomes among commercially insured adults. JAMA Netw Open. 2022;5(3):e224065. https://jamanetwork.com/journals/jamanetworkopen
- Cannon CP, Braunwald E, Murphy SA, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes (PROVE IT-TIMI 22). N Engl J Med. 2004;350(15):1495-1504. https://pubmed.ncbi.nlm.nih.gov/15007110/
- Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn
- Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,149 participants in 27 randomised trials. Lancet. 2015;385(9976):1397-1405. https://pubmed.ncbi.nlm.nih.gov/25579834/
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). N Engl J Med. 2008;359(21):2195-2207. https://pubmed.ncbi.nlm.nih.gov/18997196/